{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:22:55Z","timestamp":1788225775526,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI110375"],"award-info":[{"award-number":["AI110375"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01"],"award-info":[{"award-number":["R01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ebiom.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T19:23:21Z","timestamp":1574450601000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories"],"prefix":"10.1016","volume":"50","author":[{"given":"Nuttada","family":"Panpradist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Vrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parker S.","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enos C.","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Kanthula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Wong-On-Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Rossouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute D.","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ngo-Giang-Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laddawan","family":"Laomanit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Klavins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ebiom.2019.11.002_bib0001","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.002_bib0002","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jix544","article-title":"Prevalence of pre-antiretroviral-treatment drug resistance by gender, age, and other factors in HIV-Infected individuals initiating therapy in Kenya, 2013\u20132014","volume":"216","author":"Silverman","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2019.11.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1097\/QAI.0000000000000426","article-title":"Cost-Effectiveness of genotype testing for primary resistance in brazil","volume":"68","author":"Luz","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.002_bib0004","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","article-title":"Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness","volume":"134","author":"Weinstein","year":"2001","journal-title":"Ann Interal Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ebiom.2019.11.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109148","article-title":"Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings","volume":"9","author":"Phillips","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.002_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/cid\/cis887","article-title":"The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa","volume":"56","author":"Levison","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1472-6963-14-116","article-title":"Implementing antiretroviral resistance testing in a primary health care hiv treatment programme in rural Kwazulu-Natal, South Africa: early experiences, achievements and challenges","volume":"14","author":"Lessells","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.002_bib0009","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/S1473-3099(16)30118-9","article-title":"Affordable hiv drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan africa","volume":"16","author":"Inzaule","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"suppl_9","key":"10.1016\/j.ebiom.2019.11.002_bib0010","doi-asserted-by":"crossref","first-page":"S824","DOI":"10.1093\/infdis\/jix413","article-title":"Current status of point-of-care testing for human immunodeficiency virus drug resistance","volume":"216","author":"Duarte","year":"2017","journal-title":"J Infect Dis"},{"issue":"401","key":"10.1016\/j.ebiom.2019.11.002_bib0011","article-title":"Next-Generation sequencing to help monitor patients infected with HIV: ready for clinical use?","volume":"16","author":"Gibson RM","year":"2014","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2019.11.002_bib0012","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/jcm.33.2.342-347.1995","article-title":"Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine","volume":"33","author":"Frenkel","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.11.002_bib0013","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/JCM.02062-09","article-title":"Detection of HIV-1 drug resistance in women following administration of a single dose of nevirapine: comparison of plasma RNA to cellular DNA by consensus sequencing and by oligonucleotide ligation assay","volume":"48","author":"Wagner","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.11.002_bib0014","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir798","article-title":"A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-Infected pregnant women receiving a single intrapartum dose of nevirapine","volume":"54","author":"Van Dyke","year":"2012","journal-title":"Clin Infect Diseas Offic Publ Infect Dis Soc Am"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000001934","article-title":"Implementation of a point mutation assay for HIV drug resistance testing in Kenya","author":"Duarte","year":"2018","journal-title":"Aids"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0016","article-title":"Aquarium: the laboratory operating system (Version v2.5.0)","author":"Keller","year":"2019","journal-title":"Zenodo"},{"issue":"10","key":"10.1016\/j.ebiom.2019.11.002_bib0017","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/652151","article-title":"Nevirapine resistance by timing of hiv type 1 infection in infants treated with single\u2010dose nevirapine","volume":"50","author":"Micek Mark","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.002_bib0018","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"33","key":"10.1016\/j.ebiom.2019.11.002_bib0019","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/QAD.0000000000002134","article-title":"Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI Art in Kenyan women","volume":"6","author":"Milne","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2018.0239","article-title":"Pretreatment hiv drug resistance and virologic outcomes to first-line antiretroviral therapy in Peru","author":"Soria","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.002_bib0021","doi-asserted-by":"crossref","first-page":"e27427","DOI":"10.1371\/journal.pone.0027427","article-title":"Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis","volume":"6","author":"Ngo-Giang-Huong","year":"2011","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.ebiom.2019.11.002_bib0022","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1128\/JCM.00306-14","article-title":"Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencing","volume":"52","author":"Beck","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.11.002_bib0023","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/QAD.0000000000001446","article-title":"Persistence of hiv drug resistance among south african children given nevirapine to prevent mother-to-child-transmission","volume":"31","author":"Kanthula","year":"2017","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.ebiom.2019.11.002_bib0024","first-page":"65","article-title":"A simple sequentially rejective multple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ac801870x","article-title":"Identification of single-nucleotide polymorphisms by the oligonucleotide ligation reaction: a dna biosensor for simultaneous visual detection of both alleles","volume":"81","author":"Toubanaki","year":"2009","journal-title":"Anal Chem"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.002_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145772","article-title":"HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing","volume":"10","author":"Rhee","year":"2015","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.ebiom.2019.11.002_bib0027","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/aid.1998.14.869","article-title":"Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of hiv type 1 pol from clinical samples","volume":"14","author":"Gunthard","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"7","key":"10.1016\/j.ebiom.2019.11.002_bib0028","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/JCM.37.7.2291-2296.1999","article-title":"Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase","volume":"37","author":"Schuurman","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0029","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virusres.2016.10.019","article-title":"Deep sequencing for HIV-1 clinical management","volume":"239","author":"Casadella","year":"2017","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.ebiom.2019.11.002_bib0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000312","article-title":"Oligonucleotide ligation assay detects hiv drug resistance associated with virologic failure among antiretroviral-na\u00efve adults in Kenya","volume":"67","author":"Chung","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.ebiom.2019.11.002_bib0031","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/jix338","article-title":"Prevalence of drug-resistant minority variants in untreated HIV-1-Infected individuals with and those without transmitted drug resistance detected by sanger sequencing","volume":"216","author":"Clutter","year":"2017","journal-title":"J Infect Dis"},{"issue":"suppl_9","key":"10.1016\/j.ebiom.2019.11.002_bib0032","doi-asserted-by":"crossref","first-page":"S847","DOI":"10.1093\/infdis\/jix430","article-title":"The role of HIV-1 drug-resistant minority variants in treatment failure","volume":"216","author":"Stella-Ascariz","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.002_bib0033","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/QAI.0b013e31817ed7d7","article-title":"Optimization of the oligonucleotide ligation assay, a rapid and inexpensive test for detection of HIV-1 drug resistance mutations, for non-North American variants","volume":"48","author":"Beck","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.ebiom.2019.11.002_bib0034","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/JCM.40.4.1413-1419.2002","article-title":"Rapid and sensitive oligonucleotide ligation assay for detection of mutations in human immunodeficiency virus type 1 associated with high-level resistance to protease inhibitors","volume":"40","author":"Beck","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2019.11.002_bib0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jviromet.2014.09.005","article-title":"Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean human immunodeficiency virus type-1 subtype c","volume":"210","author":"Mutsvangwa","year":"2014","journal-title":"J Virol Methods"},{"issue":"6","key":"10.1016\/j.ebiom.2019.11.002_bib0036","article-title":"Genotyping performance evaluation of commercially available HIV-1 drug resistance test","volume":"13","author":"Blackard","year":"2018","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.002_bib0037","doi-asserted-by":"crossref","first-page":"e28184","DOI":"10.1371\/journal.pone.0028184","article-title":"Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings","volume":"6","author":"Zhou","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.ebiom.2019.11.002_bib0038","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1128\/JCM.39.12.4323-4327.2001","article-title":"Performance of applied biosystems viroseq HIV-1 genotyping system for sequence-based analysis of non-subtype b human immunodeficiency virus type 1 from Uganda","volume":"39","author":"Mracna","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ebiom.2019.11.002_bib0039","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/JCM.01669-13","article-title":"Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype c by use of a multiplex allele-specific assay","volume":"51","author":"Zhang","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"suppl_9","key":"10.1016\/j.ebiom.2019.11.002_bib0040","doi-asserted-by":"crossref","first-page":"S843","DOI":"10.1093\/infdis\/jix398","article-title":"Human immunodeficiency virus type 1 drug resistance mutations update","volume":"216","author":"Shafer","year":"2017","journal-title":"J Infect Dis"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:55:02Z","timestamp":1762455302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419307431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"alternative-id":["S2352396419307431"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.002","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OLA-Simple: A software-guided HIV-1 drug resistance test for low-resource laboratories","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}